tirzepatide shortage over I was wrong. I was assuming the best and now see it differently. You caught it. So I dug in, and the real story is worse than what I said. I called GLP-1 Saga Continues: FDA Ends

While this does not typically cause weight plateaus, the associated symptoms like anxiety, insomnia, and digestive changes can interfere with your meal planning and dietary compliance

Research shows that GLP-1 receptor agonists like semaglutide also change how the intestines absorb nutrients and water

The target and the pathway in more detail The GLP-1 receptor is a class B1 G-protein-coupled receptor with a large extracellular domain that captures the C-terminal half of the ligand before the N-terminal half inserts into the transmembrane bundle

This, the report argues, is driven by easier access to unhealthy options compared with healthier choices

Tirzepatide is administered as a once-weekly subcutaneous injection, with doses ranging from 2.5 mg to 15 mg depending on the indication and individual response